Mallinckrodt (MNKKQ)

OTC Markets
0.36
+0.03(+7.73%)
  • Volume:
    467,975
  • Bid/Ask
    0.00/0.00
  • Day's Range
    0.34 - 0.37

MNKKQ Overview

Prev. Close
0.36
Day's Range
0.34 - 0.37
Revenue
2.87B
Open
0.36
52 wk Range
0.11 - 4.24
EPS
-23.44
Volume
467,975
Market Cap
30.46M
Dividend (Yield)
N/A (N/A)
Average Volume (3m)
1,725,905
P/E Ratio
N/A
Beta
3.68
1-Year Change
-88.4%
Shares Outstanding
84,604,862
Next Earnings Date
07 Mar 2021
What is your sentiment on Mallinckrodt?
or
Market is currently closed. Voting is open during market hours.

Mallinckrodt News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong SellSellSell
Technical IndicatorsStrong BuyStrong BuyBuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyNeutralStrong SellStrong Sell

Mallinckrodt Company Profile

Mallinckrodt Company Profile

Industry
Major Drugs
Employees
3400

Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. Its segments include Specialty Brands and Specialty Generics. The Specialty Brands segment produces and markets branded pharmaceutical products and therapies. The Specialty Generics segment produces and markets specialty generic pharmaceuticals and active pharmaceutical ingredient (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. Its product portfolio includes Acthar, Inomax, Ofirmev, Therakos immunotherapy, Hemostasis products and StrataGraft.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.